Literature DB >> 11577807

Severe abdominal infections in neutropenic patients.

M Gorschlüter1, A Glasmacher, C Hahn, C Leutner, G Marklein, J Remig, I G Schmidt-Wolf, T Sauerbruch.   

Abstract

Abdominal infections are an important cause of morbidity and mortality in neutropenic patients. We present a retrospective series of 16 patients, mostly with acute leukemia, who developed severe abdominal infections during chemotherapy-induced neutropenia between 1991 and 1997. The frequency among patients with acute leukemia was 2.35% (13 of 553). Thirteen patients presented with enterocolitis and 3 patients presented with cholecystitis. Eight patients died. Bacteremia was present in 6 patients, 4 patients suffered from proven or strongly suspected fungal infections, and 1 patient suffered from cytomegalovirus infection. Early surgical management was required in a patient with intestinal obstruction, whereas other patients could be managed conservatively. Two patients with acute cholecystitis were treated with antibiotics until the end of neutropenia and then were resected. Severe abdominal injections in neutropenic patients, which are often fatal, were caused by nonbacterial microorganisms in one-fourth of the cases and could be managed conservatively in most instances.

Entities:  

Mesh:

Year:  2001        PMID: 11577807     DOI: 10.1081/cnv-100106141

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  8 in total

1.  Neutropenic enterocolitis in patients with FLT3 mutated acute myeloid leukemia undergoing induction chemotherapy with midostaurin.

Authors:  Jennifer Dotson; Adee Elhamdani; Ellen Petryna; Muhammad Omer Jamil; Mohamed Alsharedi
Journal:  Int J Hematol       Date:  2018-12-03       Impact factor: 2.490

2.  Clinically defined chemotherapy-associated bowel syndrome predicts severe complications and death in cancer patients.

Authors:  Maria J G T Vehreschild; Arne M K Meissner; Oliver Andreas Cornely; Georg Maschmeyer; Silke Neumann; Marie von Lilienfeld-Toal; Meinholf Karthaus; Mohammed Wattad; Peter Staib; Martin Hellmich; Hildegard Christ; Jörg Janne Vehreschild
Journal:  Haematologica       Date:  2011-08-22       Impact factor: 9.941

Review 3.  [Infection-related emergencies in oncology].

Authors:  X Schiel; C Rieger; H Ostermann
Journal:  Internist (Berl)       Date:  2005-01       Impact factor: 0.743

4.  Chemotherapy patients with C. difficile colitis have outcomes similar to immunocompetent C. difficile patients.

Authors:  David B Stewart; Emmanuel Yacoub; Junjia Zhu
Journal:  J Gastrointest Surg       Date:  2012-06-13       Impact factor: 3.452

5.  Neutropenic enterocolitis: is it possible to break vicious circle between neutropenia and the bowel wall inflammation by surgery?

Authors:  Baran Tokar; Sultan Aydoğdu; Ozgül Paşaoğlu; Huseyin Ilhan; Emine Kasapoğlu
Journal:  Int J Colorectal Dis       Date:  2003-05-16       Impact factor: 2.571

6.  Invasive fungal infections in neutropenic enterocolitis: a systematic analysis of pathogens, incidence, treatment and mortality in adult patients.

Authors:  Marcus Gorschlüter; Ulrich Mey; John Strehl; Volker Schmitz; Christian Rabe; Katharina Pauls; Carsten Ziske; Ingo G H Schmidt-Wolf; Axel Glasmacher
Journal:  BMC Infect Dis       Date:  2006-02-26       Impact factor: 3.090

Review 7.  The prognostic impact of abdominal surgery in cancer patients with neutropenic enterocolitis: a systematic review and meta-analysis, on behalf the Groupe de Recherche en Réanimation Respiratoire du patient d'Onco-Hématologie (GRRR-OH).

Authors:  Colombe Saillard; Lara Zafrani; Michael Darmon; Magali Bisbal; Laurent Chow-Chine; Antoine Sannini; Jean-Paul Brun; Jacques Ewald; Olivier Turrini; Marion Faucher; Elie Azoulay; Djamel Mokart
Journal:  Ann Intensive Care       Date:  2018-04-19       Impact factor: 6.925

Review 8.  Neutropenic Enterocolitis and Sepsis: Towards the Definition of a Pathologic Profile.

Authors:  Giuseppe Bertozzi; Aniello Maiese; Giovanna Passaro; Alberto Tosoni; Antonio Mirijello; Stefania De Simone; Benedetta Baldari; Luigi Cipolloni; Raffaele La Russa
Journal:  Medicina (Kaunas)       Date:  2021-06-20       Impact factor: 2.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.